Autoimmunity in common variable immunodeficiency
- 11 August 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Allergy and Asthma Reports
- Vol. 9 (5), 347-352
- https://doi.org/10.1007/s11882-009-0051-0
Abstract
Common variable immunodeficiency (CVID) is the most common clinically significant primary immune defect. Although the hallmark of CVID is hypogammaglobulinemia, the intrinsic dysregulation of the immune system leads to defective T-cell activation and proliferation, as well as dendritic cell and cytokine defects. Although 70% to 80% of patients have had recurrent sinopulmonary infections, autoimmunity and inflammatory complications are also common. The most common autoimmune conditions are immune thrombocytopenic purpura and hemolytic anemia, but other autoimmune complications arise, including rheumatoid arthritis, pernicious anemia, primary biliary cirrhosis, thyroiditis, sicca syndrome, systemic lupus, and inflammatory bowel disease. Treatment of autoimmunity includes highdose immunoglobulins, corticosteroids, selected immu no suppressants, and other immune modulators. This review focuses on autoimmune conditions associated with CVID, potential mechanisms of immune dysregulation, and therapeutic strategies.Keywords
This publication has 52 references indexed in Scilit:
- Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromesBlood, 2009
- Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiencyClinical and Experimental Immunology, 2008
- Memory B cells in common variable immunodeficiency: Clinical associations and sex differencesClinical Immunology, 2008
- Osteoarticular infectious complications in patients with primary immunodeficienciesCurrent Opinion in Rheumatology, 2008
- Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotesJournal of Allergy and Clinical Immunology, 2007
- High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiencyClinical Immunology, 2007
- Role for Msh5 in the regulation of Ig class switch recombinationProceedings of the National Academy of Sciences of the United States of America, 2007
- Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiencyNature Genetics, 2007
- Rheumatoid arthritis in a patient with common variable immunodeficiency:difficulty in diagnosis and therapyClinical Rheumatology, 2005
- Expansion of CD19CD21 B Cells in Common Variable Immunodeficiency (CVID) Patients with Autoimmune CytopeniaImmunobiology, 2002